Schizophrenia Management: Facilitating Evidence-Based Individualized Treatment for Optimal Patient Management
Provided by The France Foundation.
This activity is supported by an educational grant from Alkermes.
Scroll to the Bottom of this Information to Begin this Course
Release date: July 29, 2016
Valid through: July 29, 2017
Estimated Time to Complete Activity: 60 minutes
- Health care providers specializing in mental health and others who support the needs of patients with mental health disorders
Participants will be presented with multiple patient cases. Each scenario will require participants to review relevant diagnostic and case history; respond to assessment and behavior questions; and make management decisions.
Upon completion of this activity, participants should be better able to:
- Apply key evidence from guidance and robust studies to clinical decisions for patients with schizophrenia in order to achieve the highest possible efficacy and prevent relapses.
- Demonstrate appropriate use of objective measure, eg, symptom rating scales, as a means of quantifying schizophrenia symptomatology and response to treatment.
- Evaluate the overuse/ inappropriate use of polypharmacy.
- Apply available evidence on effective titration or switching of antipsychotics to clinical scenarios in which the patient is not responsive to (or cannot tolerate) the initial regimen.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Henry Nasrallah, MD
Professor & Chairman
Department of Psychiatry
And the Sydney W. Souers Endowed Chair
Saint Louis University School of Medicine
Physician Continuing Medical Education
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The France Foundation designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME-accredited provider.
Disclosures of Conflicts of Interest
- Consultant: Acacia, Alkermes, Allergan, Janssen, Otsuka, Sunovion, and Vanda
- Received Honoraria: Acacia, Alkermes, Allergan, Janssen, Otsuka, Sunovion, and Vanda
Instructions for Participation and Credit
Method Of Participation / How To Receive Credit
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Complete the CME/CE activity.
- Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
- Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
- Credit documentation/reporting: If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Disclosure of Unlabeled Use
The France Foundation requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. The France Foundation does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter assume no liability for the information herein.
Click here for a downloadable PDF on schizophrenia management